Pharmacia/Xalcom
Executive Summary
Xalatan (latanoprost) and timolol (Merck's Timoptic and generics) fixed combination product receives second FDA "approvable" letter Oct. 19 for second-line use to reduce intraocular pressure in patients with open-angle glaucoma or ocular hypertension